Search results
Results from the Health.Zone Content Network
McKesson expects 2024 adjusted profit of $26.55 to $27.35 per share, from a prior forecast of $26.10 to $26.90 per share. Analysts estimate a profit of $26.63. Excluding items, the company ...
The Texas-headquartered company forecast 2025 adjusted per-share profit of $31.25 to $32.05, above analysts' average estimate of $31.02 per share, according to LSEG data.
McKesson Corporation is an American company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees. McKesson had revenues of $276 billion in its fiscal year ending March 31 ...
McKesson's (MCK) fiscal second-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.
McKesson Europe AG (formerly Celesio AG, previously Gehe AG), with its headquarters in Stuttgart, Germany, is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year (31 March 2019) and ...
Language links are at the top of the page. Search. Search
The mid-point of the company's 2020 adjusted profit outlook of between $13.85 and $14.45 per share was a cent above the average analyst estimate, according to IBES data from Refinitiv.
Saint Paul, Minnesota, Minnesota. Occupation (s) CEO of McKesson Corporation, Retired. John H. Hammergren is an American businessman. He is best known for his role as chairman and CEO of McKesson Corporation since 1999. [1] On November 1, 2018, Hammergren announced his plan to retire. [2] On April 1, 2019, he officially retired from McKesson.